Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 09:30 ET | Source: John Snow Labs

John Snow Labs Wins Real World Evidence Catalyst Challenge at PHUSE US Connect 2026

John Snow Labs recognized for its groundbreaking framework for automating oncology data abstraction at PHUSE US Connect 2026.
March 24, 2026 09:00 ET | Source: SurvivorRx

SurvivorRx Expands Personalized Supplement Routines as Oncologists Raise Concerns About Supplement Safety for Cancer Survivors

New oncologist formulated supplement systems aim to simplify wellness while addressing safety, dosing, and formulation challenges many survivors face.
March 24, 2026 08:45 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain

The goal is to strengthen our intellectual property and to better understand how PRP technology can overcome resistant tumors and age-related diseases.
March 24, 2026 08:00 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials

SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic...
March 23, 2026 11:15 ET | Source: Siren Biotechnology, Inc.

Siren Biotechnology Announces FDA Clearance of Investigator-Initiated IND to Advance Phase 1 Study in Recurrent High-Grade Glioma

Siren Biotechnology Announces FDA Clearance of Investigator-Initiated IND to Advance Phase 1 Study in Recurrent High-Grade Glioma
March 23, 2026 08:06 ET | Source: Inspire

Inspire and HPV Cancers Alliance Launch New Online Community for People Affected by HPV-Related Cancers

Arlington, VA, March 23, 2026 (GLOBE NEWSWIRE) -- Inspire, the world’s largest online community for patients and caregivers, today announced the launch of a new online community in partnership with...
March 23, 2026 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...
March 20, 2026 07:48 ET | Source: Crosetto Foundation for the Reduction of Cancer Deaths

Scientist Challenges CERN and Industry to Public ‘Known Dataset Test’ to Prove 3D-Flow Can Save Billions and Millions of Lives

Scientist Dario Crosetto challenges CERN to a ‘Known Dataset Test’ at the TBPET 2026 Conference to prove 3D-Flow can save >$12B and millions of lives
March 20, 2026 02:00 ET | Source: Novartis Pharma AG

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-) breast cancer The lead asset, SNV4818,...
March 18, 2026 08:36 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

OCALA, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Japan Patent Office has fully approved a Japanese patent...